Transurethral Partial Cystectomy With Continuous Wave Laser for Bladder Carcinoma

Yang, Yong; Wei, Zhitao; Zhang, Xu; Hong, Bao-fa; Guo, Gang

doi:10.1016/j.juro.2009.02.154

Cited by 22 publications

(15 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Laserunterstützende Anwendungen bei der En-bloc-Resektion von Harnblasentumoren sind ebenfalls beschrieben. Jeweils 4 Publikationen beziehen sich auf den Gebrauch des Holmium:YAG-Lasers (Ho:YAG, HoLRBT; [14,19,20,21]) sowie auf den des Thulium:YAG-Lasers (Tm:YAG, TmLRBT; [19,22,23,24];…”

Section: Studienlageunclassified

“…Um eine R0-Resektion sicherzustellen, biopsierten einige Arbeitsgruppen den Tumorgrund [14,18,19,22,23]. Eine chinesische Arbeitsgruppe erweiterte den Eingriff zu einer partiellen Zystektomie [24]. Bei dieser Form wurden papilläre Tumoren ≤3 cm mit der gesamten Harnblasenwand unter Einbeziehung der Detrusormuskulatur samt Anteilen des darunter liegenden Fettgewebes entfernt.…”

Section: Technische Aspekteunclassified

“…Unter Einsatz der monopolaren Schlinge berichten Lodde et al [13] von einer nachgewiesenen Blasenperforation bei insgesamt 37 behandelten Patienten. Eine weitere Perforation wird bei der Anwendung eines Tm:YAG-Lasers angezeigt [24]. Allerdings muss darauf hingewiesen werden, dass es sich hierbei um eine gezielte Abtragung der kompletten Blasenwand bis in das perivesikuläre Fettgewebe im Bereich des Tumors handelte.…”

Section: Perioperative Und Postoperative Morbiditätunclassified

“…Die in theoretischen Überlegungen verbesserte Hämostase unter Einsatz von Lasern [25] bestätigte sich in mehreren Fallberichten [19,20,21,23,24]. Haben Xishuang et al [21] dies in der reinen Gegenüberstellung der verwendeten Methoden empirisch beschrieben, jedoch keine messbaren Daten publiziert, so verzeichneten Zhong et al [19] …”

Section: Introductionunclassified

See 3 more Smart Citations

Transurethrale En-bloc-Resektion nicht muskelinvasiver Harnblasenkarzinome

Kramer

Wolters

Abdelkawi

et al. 2012

Urologe

View full text Add to dashboard Cite

Bladder cancer of the urothelium is the second most common malignancy among urological tumors. In view of a worldwide aging population and the fact that increased incidence rates are associated with higher age, new socioeconomic challenges will appear. Even nowadays the treatment of bladder cancer bears the highest lifetime treatment costs per patient among all forms of cancer. In conjunction with higher comorbidity rates among older patients urologists are facing new challenges in the treatment and care of patients with bladder cancer. The standard treatment for non-muscle invasive bladder cancer (NMIBC) is monopolar transurethral resection using resection loops (TURB). Based on experience in the surgical treatment of benign prostatic hyperplasia, different concepts of en bloc resection of bladder tumors using alternative energy resources (e.g. holmium laser, thulium laser and the water-jet HybridKnife) have been developed. Goals of new treatment modalities are reduction of perioperative and postoperative comorbidities, better pathological work-up of the specimens and increased recurrence-free survival. Postulated advantages using laser devices are a more precise cutting line as well as better hemostasis. The evidential value of this review is limited due to the lack of randomized, prospective studies. However, there is a tendency towards a limitation of perioperative and postoperative morbidities as well as higher chance of well-preserved tissues for better pathohistological evaluation using en bloc resection methods. More studies with long-term follow-up periods and better randomization are needed to clarify whether en bloc strategies provide better long-term oncological survival.

show abstract

Section: Studienlageunclassified

Section: Technische Aspekteunclassified

Section: Perioperative Und Postoperative Morbiditätunclassified

Section: Introductionunclassified

See 2 more Smart Citations

Transurethrale En-bloc-Resektion nicht muskelinvasiver Harnblasenkarzinome

Kramer

Wolters

Abdelkawi

et al. 2012

Urologe

View full text Add to dashboard Cite

show abstract

“…There was minimal hemorrhage perioperatively, the histologic structure was clear, the range of excision was precise, and the operation was easy to control. 11 Vaporesection with the 2013 nm thulium continuous wave laser has already been used successfully as a minimally invasive treatment for patients with bladder tumor. Because of its characteristics of simultaneous precise vaporization, as well as resection and bladder wall anatomic characteristics, we applied the 2013 nm thulium laser for endourologic management of bladder pheochromocytoma.…”

mentioning

confidence: 99%